Skip to main content

MEA Parenteral Nutrition Market Will Secure 7.1% from 2020 to 2024

 MEA parenteral nutrition market is expected to display a CAGR of 7.1% in the forthcoming period owing to variables such as increase in premature births, vulnerability to malnutrition, and increasing prevalence of cancers. In addition, existing malnourished children and premature neonates with a specific need for parenteral nutrition propels the market growth in the near future. With the rise in supply of parenteral nutrition, the regions have witnessed a strong decline in the prevalence of chronic disease and malnourishment.

Driving factors responsible for MEA parenteral nutrition market include decline in child mortality rate and improved healthcare settings. Rise in improved birth rate with enhanced nutrition levels is expected to bolster MEA market during the forecast period. Malnutrition is one of the primary drivers for MEA parenteral nutrition industry. Secondary drivers include prevalence of chronic conditions and administration of important nutrients that help in maintaining energy, strength and hydration level.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/mea-parenteral-nutrition-market/request-sample

Nutrient type for MEA parenteral nutrition market includes single amino dose acid, trace elements, vitamins & minerals, carbohydrates, and parenteral lipid emulsions. Simple dose amino acid dominates the market segment in the forecast period owing to substantial increase in supply of medical formulations.

Geographical segmentation for MEA parenteral nutrition market include Saudi Arabia, Kuwait, Oman, Jordan, Lebanon, and UAE. Saudi Arabia accounted for a significant market share in 2016followed by Kuwait, Oman, Jordan, and Lebanon. Rise in healthcare settings, increase in awareness and rise in healthcare expenditure is likely to support the market growth in MEA regions. Healthcare settings in UAE witnesses several improvements resulting out of significant investments by local government.

The key players in the MEA parenteral nutrition industry includes B. Braun Melsungen AG; Baxter; Fresenius Kabi AG; Hospira Inc.; Qatar Pharma Factory; Pharmaceutical Solutions Industry; Kuwait Saudi Pharmaceutical Industries Co.; Alfa Laboratories; and Well Pharma.

 

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/mea-parenteral-nutrition-market

MEA Parenteral Nutrition Nutrient Type Outlook (Revenue, USD Million; 2014 - 2025)
    • Carbohydrate
    • Parenteral Lipid Emulsions
    • Single Dose Amino Acid Solutions
    • Trace Elements
    • Vitamins and Minerals

MEA Parenteral Nutrition Dosage Form Outlook (Revenue, USD Million; 2014 - 2025)
    • Vials
    • Ampoules
    • Bottles
    • Bags
        • Multi chambered bags
        • Other bags

MEA Parenteral Nutrition Regional Outlook (Revenue, USD Million; 2014 - 2025)
    • Saudi Arabia
    • Qatar
    • Kuwait
    • UAE
    • Oman
    • Egypt
    • Lebanon
    • Jordan

Comments

Popular posts from this blog

Aesthetic Medicine Market Worth About USD 11.9 billion By 2024

  Global Aesthetic Medicine Market is anticipated to reach USD 11.9 billion by 2022. Aesthetic medicine is a wide-ranging term for specialties that emphasize on improving cosmetic appearance through the treatment of situations including skin laxity, scars, wrinkles, excess fat, unwanted hair, skin discoloration. The factors that propel the growth of the Aesthetic Medicine Market include rising awareness regarding aesthetic procedures. In addition, growing demand for the use of minimally invasive equipment, rapid technological advancement, and increase in disposable incomes. On the other hand, there are factors that may hamper the growth of the market including poor compensation structures and probable health risks related with the procedures. The market is anticipated to grow at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe. Market may be explored by product type, application, and geography. Aesthetic M...

Paint Additives Market To Show Tremendous Rise In Upcoming Year

Paint additives market is expected to reach USD 10.9 billion by 2025. Growing use of paints and coatings in the construction and the automotive sectors due to highly preferred solvent properties are major growth factors. Other factors such as increase in the expenditure on construction activities and rise in the adoption of paints and coatings in automotive sector, are fueling growth of the paint additives market, mainly in developing economies across the globe. The increasing use of paints and coating is expected to influence demand for paint additives in the forecast period. Paint additives market is expected to witness 6% CAGR in the forecast period. The stringent laws and regulation against harmful effects of paints and coating on environment are compelling market players to adopt environment-friendly paints and coatings additives that complies with the regional and international regulations. This has led market players to significantly invest in research and development for pain...

Thyroid Gland Disorder Treatment Market Worth About 2.6 billion By 2024

Thyroid Gland Disorder Treatment Market is estimated to stretch US$ 2.6 billion by the year 2025. Growth in occurrence of thyroid diseases, everywhere in the world, is likely to motivate the demand for anti-thyroid medications in the approaching years. Hypothyroidism is one of the most important reasons for hospitalization in the U.S. Increasing consciousness about sickness administration between healthcare specialists and patients is additional reason boosting the progress of the market. The thyroid gland disorder treatment industry will develop by a CAGR of 3.2% for the duration of the prediction. The thyroid gland disorder treatment market on the source of Type of Delivery Network could span Online Delivery, Wholesaler/Distributors, Retail Chain, and Others. The wholesalers and distributors form a somewhat complete subdivision. Yet, greater infiltration of these delivery networks for prescription medicines has permitted it to increase the biggest income stake since 2016. Wholesale...